Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.83 | N/A |
| PEG Ratio (TTM) | 0.27 | N/A |
| P/S Ratio (TTM) | 2.39 | N/A |
| P/B Ratio (TTM) | 1.11 | N/A |
| P/FCF Ratio (TTM) | 44.25 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.20 | N/A |
| Price to 5YR AVG FCF Ratio | 12.93 | N/A |
Profitability (65%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.10% | N/A |
| ROE (TTM) | 11.26% | N/A |
| Net Profit Margin (TTM) | 22.12% | N/A |
| ROIC 5YR AVG | 20.83% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -79.16% | 2.12% | 17.56% |
| Revenue | 44.34% | 0.90% | 278.37% |
| Net Income | 17.10% | -0.32% | 15.60% |
| Cash Flow | 23.39% | 112.84% | 57.99% |
Health (81%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 63.78 | N/A |
| Quick Ratio (TTM) | 63.78 | N/A |
| D/E Ratio (TTM) | 0.32 | N/A |
| Interest Coverage (TTM) | 0.02 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 0.53 | N/A |
| LTL to 5YR AVG FCF | 3.72 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.98% | N/A |